Bioenergetics of acquired cisplatin resistant H1299 non-small cell lung cancer and P31 mesothelioma cells

Acquired cisplatin resistance is a common feature of tumours following cancer treatment with cisplatin and also of non-small cell lung cancer (H1299) and mesothelioma (P31) cell lines exposed to cisplatin. To elucidate the cellular basis of acquired cisplatin resistance, a comprehensive bioenergetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Geoghegan, Fintan, Buckland, Robert J., Rogers, Eric T., Khalifa, Karima, O’Connor, Emma B., Rooney, Mary F., Behnam-Motlagh, Parviz, Nilsson, Torbjörn K., Grankvist, Kjell, Porter, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706906/
https://www.ncbi.nlm.nih.gov/pubmed/29212260
http://dx.doi.org/10.18632/oncotarget.21885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706906/
https://www.ncbi.nlm.nih.gov/pubmed/29212260
http://dx.doi.org/10.18632/oncotarget.21885

Ejemplares similares